Successful trial of itolizumab which significantly reduced mortality in patients hospitalized with COVID-19.- Equillium + Biocon
Equillium, Inc., announced that as reported by its partner, Biocon Limited, a clinical trial conducted in India by Biocon demonstrated that itolizumab significantly reduced mortality in patients hospitalized… read more.